1 Study Coverage 1.1 Anca Vasculitis Drug Product Introduction 1.2 Market by Type 1.2.1 Global Anca Vasculitis Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Belimumab 1.2.3 CCX-1378 1.2.4 CCX-168 1.2.5 Dalazatide 1.2.6 Others 1.3 Market by Application 1.3.1 Global Anca Vasculitis Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Anca Vasculitis Drug Sales Estimates and Forecasts 2017-2028 2.2 Global Anca Vasculitis Drug Revenue Estimates and Forecasts 2017-2028 2.3 Global Anca Vasculitis Drug Revenue by Region: 2017 VS 2021 VS 2028 2.4 Global Anca Vasculitis Drug Sales by Region 2.4.1 Global Anca Vasculitis Drug Sales by Region (2017-2022) 2.4.2 Global Sales Anca Vasculitis Drug by Region (2023-2028) 2.5 Global Anca Vasculitis Drug Revenue by Region 2.5.1 Global Anca Vasculitis Drug Revenue by Region (2017-2022) 2.5.2 Global Anca Vasculitis Drug Revenue by Region (2023-2028) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global Anca Vasculitis Drug Sales by Manufacturers 3.1.1 Global Top Anca Vasculitis Drug Manufacturers by Sales (2017-2022) 3.1.2 Global Anca Vasculitis Drug Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Anca Vasculitis Drug in 2021 3.2 Global Anca Vasculitis Drug Revenue by Manufacturers 3.2.1 Global Anca Vasculitis Drug Revenue by Manufacturers (2017-2022) 3.2.2 Global Anca Vasculitis Drug Revenue Market Share by Manufacturers (2017-2022) 3.2.3 Global Top 10 and Top 5 Companies by Anca Vasculitis Drug Revenue in 2021 3.3 Global Anca Vasculitis Drug Sales Price by Manufacturers (2017-2022) 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Anca Vasculitis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Anca Vasculitis Drug Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Anca Vasculitis Drug Sales by Type 4.1.1 Global Anca Vasculitis Drug Historical Sales by Type (2017-2022) 4.1.2 Global Anca Vasculitis Drug Forecasted Sales by Type (2023-2028) 4.1.3 Global Anca Vasculitis Drug Sales Market Share by Type (2017-2028) 4.2 Global Anca Vasculitis Drug Revenue by Type 4.2.1 Global Anca Vasculitis Drug Historical Revenue by Type (2017-2022) 4.2.2 Global Anca Vasculitis Drug Forecasted Revenue by Type (2023-2028) 4.2.3 Global Anca Vasculitis Drug Revenue Market Share by Type (2017-2028) 4.3 Global Anca Vasculitis Drug Price by Type 4.3.1 Global Anca Vasculitis Drug Price by Type (2017-2022) 4.3.2 Global Anca Vasculitis Drug Price Forecast by Type (2023-2028) 5 Market Size by Application 5.1 Global Anca Vasculitis Drug Sales by Application 5.1.1 Global Anca Vasculitis Drug Historical Sales by Application (2017-2022) 5.1.2 Global Anca Vasculitis Drug Forecasted Sales by Application (2023-2028) 5.1.3 Global Anca Vasculitis Drug Sales Market Share by Application (2017-2028) 5.2 Global Anca Vasculitis Drug Revenue by Application 5.2.1 Global Anca Vasculitis Drug Historical Revenue by Application (2017-2022) 5.2.2 Global Anca Vasculitis Drug Forecasted Revenue by Application (2023-2028) 5.2.3 Global Anca Vasculitis Drug Revenue Market Share by Application (2017-2028) 5.3 Global Anca Vasculitis Drug Price by Application 5.3.1 Global Anca Vasculitis Drug Price by Application (2017-2022) 5.3.2 Global Anca Vasculitis Drug Price Forecast by Application (2023-2028) 6 North America 6.1 North America Anca Vasculitis Drug Market Size by Type 6.1.1 North America Anca Vasculitis Drug Sales by Type (2017-2028) 6.1.2 North America Anca Vasculitis Drug Revenue by Type (2017-2028) 6.2 North America Anca Vasculitis Drug Market Size by Application 6.2.1 North America Anca Vasculitis Drug Sales by Application (2017-2028) 6.2.2 North America Anca Vasculitis Drug Revenue by Application (2017-2028) 6.3 North America Anca Vasculitis Drug Market Size by Country 6.3.1 North America Anca Vasculitis Drug Sales by Country (2017-2028) 6.3.2 North America Anca Vasculitis Drug Revenue by Country (2017-2028) 6.3.3 U.S. 6.3.4 Canada 7 Europe 7.1 Europe Anca Vasculitis Drug Market Size by Type 7.1.1 Europe Anca Vasculitis Drug Sales by Type (2017-2028) 7.1.2 Europe Anca Vasculitis Drug Revenue by Type (2017-2028) 7.2 Europe Anca Vasculitis Drug Market Size by Application 7.2.1 Europe Anca Vasculitis Drug Sales by Application (2017-2028) 7.2.2 Europe Anca Vasculitis Drug Revenue by Application (2017-2028) 7.3 Europe Anca Vasculitis Drug Market Size by Country 7.3.1 Europe Anca Vasculitis Drug Sales by Country (2017-2028) 7.3.2 Europe Anca Vasculitis Drug Revenue by Country (2017-2028) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific Anca Vasculitis Drug Market Size by Type 8.1.1 Asia Pacific Anca Vasculitis Drug Sales by Type (2017-2028) 8.1.2 Asia Pacific Anca Vasculitis Drug Revenue by Type (2017-2028) 8.2 Asia Pacific Anca Vasculitis Drug Market Size by Application 8.2.1 Asia Pacific Anca Vasculitis Drug Sales by Application (2017-2028) 8.2.2 Asia Pacific Anca Vasculitis Drug Revenue by Application (2017-2028) 8.3 Asia Pacific Anca Vasculitis Drug Market Size by Region 8.3.1 Asia Pacific Anca Vasculitis Drug Sales by Region (2017-2028) 8.3.2 Asia Pacific Anca Vasculitis Drug Revenue by Region (2017-2028) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 8.3.12 Philippines 9 Latin America 9.1 Latin America Anca Vasculitis Drug Market Size by Type 9.1.1 Latin America Anca Vasculitis Drug Sales by Type (2017-2028) 9.1.2 Latin America Anca Vasculitis Drug Revenue by Type (2017-2028) 9.2 Latin America Anca Vasculitis Drug Market Size by Application 9.2.1 Latin America Anca Vasculitis Drug Sales by Application (2017-2028) 9.2.2 Latin America Anca Vasculitis Drug Revenue by Application (2017-2028) 9.3 Latin America Anca Vasculitis Drug Market Size by Country 9.3.1 Latin America Anca Vasculitis Drug Sales by Country (2017-2028) 9.3.2 Latin America Anca Vasculitis Drug Revenue by Country (2017-2028) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Anca Vasculitis Drug Market Size by Type 10.1.1 Middle East and Africa Anca Vasculitis Drug Sales by Type (2017-2028) 10.1.2 Middle East and Africa Anca Vasculitis Drug Revenue by Type (2017-2028) 10.2 Middle East and Africa Anca Vasculitis Drug Market Size by Application 10.2.1 Middle East and Africa Anca Vasculitis Drug Sales by Application (2017-2028) 10.2.2 Middle East and Africa Anca Vasculitis Drug Revenue by Application (2017-2028) 10.3 Middle East and Africa Anca Vasculitis Drug Market Size by Country 10.3.1 Middle East and Africa Anca Vasculitis Drug Sales by Country (2017-2028) 10.3.2 Middle East and Africa Anca Vasculitis Drug Revenue by Country (2017-2028) 10.3.3 Turkey 10.3.4 Saudi Arabia 11 Company Profiles 11.1 ChemoCentryx, Inc. 11.1.1 ChemoCentryx, Inc. Corporation Information 11.1.2 ChemoCentryx, Inc. Overview 11.1.3 ChemoCentryx, Inc. Anca Vasculitis Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.1.4 ChemoCentryx, Inc. Anca Vasculitis Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 ChemoCentryx, Inc. Recent Developments 11.2 GlaxoSmithKline plc 11.2.1 GlaxoSmithKline plc Corporation Information 11.2.2 GlaxoSmithKline plc Overview 11.2.3 GlaxoSmithKline plc Anca Vasculitis Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.2.4 GlaxoSmithKline plc Anca Vasculitis Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 GlaxoSmithKline plc Recent Developments 11.3 Kineta, Inc. 11.3.1 Kineta, Inc. Corporation Information 11.3.2 Kineta, Inc. Overview 11.3.3 Kineta, Inc. Anca Vasculitis Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.3.4 Kineta, Inc. Anca Vasculitis Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 Kineta, Inc. Recent Developments 12 Industry Chain and Sales Channels Analysis 12.1 Anca Vasculitis Drug Industry Chain Analysis 12.2 Anca Vasculitis Drug Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Anca Vasculitis Drug Production Mode & Process 12.4 Anca Vasculitis Drug Sales and Marketing 12.4.1 Anca Vasculitis Drug Sales Channels 12.4.2 Anca Vasculitis Drug Distributors 12.5 Anca Vasculitis Drug Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Anca Vasculitis Drug Industry Trends 13.2 Anca Vasculitis Drug Market Drivers 13.3 Anca Vasculitis Drug Market Challenges 13.4 Anca Vasculitis Drug Market Restraints 14 Key Findings in The Global Anca Vasculitis Drug Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer

List of Tables Table 1. Global Anca Vasculitis Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million) Table 2. Major Manufacturers of Belimumab Table 3. Major Manufacturers of CCX-1378 Table 4. Major Manufacturers of CCX-168 Table 5. Major Manufacturers of Dalazatide Table 6. Major Manufacturers of Others Table 7. Global Anca Vasculitis Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million) Table 8. Global Anca Vasculitis Drug Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million) Table 9. Global Anca Vasculitis Drug Sales by Region (2017-2022) & (K Pcs) Table 10. Global Anca Vasculitis Drug Sales Market Share by Region (2017-2022) Table 11. Global Anca Vasculitis Drug Sales by Region (2023-2028) & (K Pcs) Table 12. Global Anca Vasculitis Drug Sales Market Share by Region (2023-2028) Table 13. Global Anca Vasculitis Drug Revenue by Region (2017-2022) & (US$ Million) Table 14. Global Anca Vasculitis Drug Revenue Market Share by Region (2017-2022) Table 15. Global Anca Vasculitis Drug Revenue by Region (2023-2028) & (US$ Million) Table 16. Global Anca Vasculitis Drug Revenue Market Share by Region (2023-2028) Table 17. Global Anca Vasculitis Drug Sales by Manufacturers (2017-2022) & (K Pcs) Table 18. Global Anca Vasculitis Drug Sales Share by Manufacturers (2017-2022) Table 19. Global Anca Vasculitis Drug Revenue by Manufacturers (2017-2022) & (US$ Million) Table 20. Global Anca Vasculitis Drug Revenue Share by Manufacturers (2017-2022) Table 21. Anca Vasculitis Drug Price by Manufacturers (2017-2022) &(USD/Pcs) Table 22. Global Anca Vasculitis Drug Manufacturers Market Concentration Ratio (CR5 and HHI) Table 23. Global Anca Vasculitis Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anca Vasculitis Drug as of 2021) Table 24. Anca Vasculitis Drug Manufacturing Base Distribution and Headquarters Table 25. Manufacturers Anca Vasculitis Drug Product Offered Table 26. Date of Manufacturers Enter into Anca Vasculitis Drug Market Table 27. Mergers & Acquisitions, Expansion Plans Table 28. Global Anca Vasculitis Drug Sales by Type (2017-2022) & (K Pcs) Table 29. Global Anca Vasculitis Drug Sales by Type (2023-2028) & (K Pcs) Table 30. Global Anca Vasculitis Drug Sales Share by Type (2017-2022) Table 31. Global Anca Vasculitis Drug Sales Share by Type (2023-2028) Table 32. Global Anca Vasculitis Drug Revenue by Type (2017-2022) & (US$ Million) Table 33. Global Anca Vasculitis Drug Revenue by Type (2023-2028) & (US$ Million) Table 34. Global Anca Vasculitis Drug Revenue Share by Type (2017-2022) Table 35. Global Anca Vasculitis Drug Revenue Share by Type (2023-2028) Table 36. Anca Vasculitis Drug Price by Type (2017-2022) & (USD/Pcs) Table 37. Global Anca Vasculitis Drug Price Forecast by Type (2023-2028) & (USD/Pcs) Table 38. Global Anca Vasculitis Drug Sales by Application (2017-2022) & (K Pcs) Table 39. Global Anca Vasculitis Drug Sales by Application (2023-2028) & (K Pcs) Table 40. Global Anca Vasculitis Drug Sales Share by Application (2017-2022) Table 41. Global Anca Vasculitis Drug Sales Share by Application (2023-2028) Table 42. Global Anca Vasculitis Drug Revenue by Application (2017-2022) & (US$ Million) Table 43. Global Anca Vasculitis Drug Revenue by Application (2023-2028) & (US$ Million) Table 44. Global Anca Vasculitis Drug Revenue Share by Application (2017-2022) Table 45. Global Anca Vasculitis Drug Revenue Share by Application (2023-2028) Table 46. Anca Vasculitis Drug Price by Application (2017-2022) & (USD/Pcs) Table 47. Global Anca Vasculitis Drug Price Forecast by Application (2023-2028) & (USD/Pcs) Table 48. North America Anca Vasculitis Drug Sales by Type (2017-2022) & (K Pcs) Table 49. North America Anca Vasculitis Drug Sales by Type (2023-2028) & (K Pcs) Table 50. North America Anca Vasculitis Drug Revenue by Type (2017-2022) & (US$ Million) Table 51. North America Anca Vasculitis Drug Revenue by Type (2023-2028) & (US$ Million) Table 52. North America Anca Vasculitis Drug Sales by Application (2017-2022) & (K Pcs) Table 53. North America Anca Vasculitis Drug Sales by Application (2023-2028) & (K Pcs) Table 54. North America Anca Vasculitis Drug Revenue by Application (2017-2022) & (US$ Million) Table 55. North America Anca Vasculitis Drug Revenue by Application (2023-2028) & (US$ Million) Table 56. North America Anca Vasculitis Drug Sales by Country (2017-2022) & (K Pcs) Table 57. North America Anca Vasculitis Drug Sales by Country (2023-2028) & (K Pcs) Table 58. North America Anca Vasculitis Drug Revenue by Country (2017-2022) & (US$ Million) Table 59. North America Anca Vasculitis Drug Revenue by Country (2023-2028) & (US$ Million) Table 60. Europe Anca Vasculitis Drug Sales by Type (2017-2022) & (K Pcs) Table 61. Europe Anca Vasculitis Drug Sales by Type (2023-2028) & (K Pcs) Table 62. Europe Anca Vasculitis Drug Revenue by Type (2017-2022) & (US$ Million) Table 63. Europe Anca Vasculitis Drug Revenue by Type (2023-2028) & (US$ Million) Table 64. Europe Anca Vasculitis Drug Sales by Application (2017-2022) & (K Pcs) Table 65. Europe Anca Vasculitis Drug Sales by Application (2023-2028) & (K Pcs) Table 66. Europe Anca Vasculitis Drug Revenue by Application (2017-2022) & (US$ Million) Table 67. Europe Anca Vasculitis Drug Revenue by Application (2023-2028) & (US$ Million) Table 68. Europe Anca Vasculitis Drug Sales by Country (2017-2022) & (K Pcs) Table 69. Europe Anca Vasculitis Drug Sales by Country (2023-2028) & (K Pcs) Table 70. Europe Anca Vasculitis Drug Revenue by Country (2017-2022) & (US$ Million) Table 71. Europe Anca Vasculitis Drug Revenue by Country (2023-2028) & (US$ Million) Table 72. Asia Pacific Anca Vasculitis Drug Sales by Type (2017-2022) & (K Pcs) Table 73. Asia Pacific Anca Vasculitis Drug Sales by Type (2023-2028) & (K Pcs) Table 74. Asia Pacific Anca Vasculitis Drug Revenue by Type (2017-2022) & (US$ Million) Table 75. Asia Pacific Anca Vasculitis Drug Revenue by Type (2023-2028) & (US$ Million) Table 76. Asia Pacific Anca Vasculitis Drug Sales by Application (2017-2022) & (K Pcs) Table 77. Asia Pacific Anca Vasculitis Drug Sales by Application (2023-2028) & (K Pcs) Table 78. Asia Pacific Anca Vasculitis Drug Revenue by Application (2017-2022) & (US$ Million) Table 79. Asia Pacific Anca Vasculitis Drug Revenue by Application (2023-2028) & (US$ Million) Table 80. Asia Pacific Anca Vasculitis Drug Sales by Region (2017-2022) & (K Pcs) Table 81. Asia Pacific Anca Vasculitis Drug Sales by Region (2023-2028) & (K Pcs) Table 82. Asia Pacific Anca Vasculitis Drug Revenue by Region (2017-2022) & (US$ Million) Table 83. Asia Pacific Anca Vasculitis Drug Revenue by Region (2023-2028) & (US$ Million) Table 84. Latin America Anca Vasculitis Drug Sales by Type (2017-2022) & (K Pcs) Table 85. Latin America Anca Vasculitis Drug Sales by Type (2023-2028) & (K Pcs) Table 86. Latin America Anca Vasculitis Drug Revenue by Type (2017-2022) & (US$ Million) Table 87. Latin America Anca Vasculitis Drug Revenue by Type (2023-2028) & (US$ Million) Table 88. Latin America Anca Vasculitis Drug Sales by Application (2017-2022) & (K Pcs) Table 89. Latin America Anca Vasculitis Drug Sales by Application (2023-2028) & (K Pcs) Table 90. Latin America Anca Vasculitis Drug Revenue by Application (2017-2022) & (US$ Million) Table 91. Latin America Anca Vasculitis Drug Revenue by Application (2023-2028) & (US$ Million) Table 92. Latin America Anca Vasculitis Drug Sales by Country (2017-2022) & (K Pcs) Table 93. Latin America Anca Vasculitis Drug Sales by Country (2023-2028) & (K Pcs) Table 94. Latin America Anca Vasculitis Drug Revenue by Country (2017-2022) & (US$ Million) Table 95. Latin America Anca Vasculitis Drug Revenue by Country (2023-2028) & (US$ Million) Table 96. Middle East and Africa Anca Vasculitis Drug Sales by Type (2017-2022) & (K Pcs) Table 97. Middle East and Africa Anca Vasculitis Drug Sales by Type (2023-2028) & (K Pcs) Table 98. Middle East and Africa Anca Vasculitis Drug Revenue by Type (2017-2022) & (US$ Million) Table 99. Middle East and Africa Anca Vasculitis Drug Revenue by Type (2023-2028) & (US$ Million) Table 100. Middle East and Africa Anca Vasculitis Drug Sales by Application (2017-2022) & (K Pcs) Table 101. Middle East and Africa Anca Vasculitis Drug Sales by Application (2023-2028) & (K Pcs) Table 102. Middle East and Africa Anca Vasculitis Drug Revenue by Application (2017-2022) & (US$ Million) Table 103. Middle East and Africa Anca Vasculitis Drug Revenue by Application (2023-2028) & (US$ Million) Table 104. Middle East and Africa Anca Vasculitis Drug Sales by Country (2017-2022) & (K Pcs) Table 105. Middle East and Africa Anca Vasculitis Drug Sales by Country (2023-2028) & (K Pcs) Table 106. Middle East and Africa Anca Vasculitis Drug Revenue by Country (2017-2022) & (US$ Million) Table 107. Middle East and Africa Anca Vasculitis Drug Revenue by Country (2023-2028) & (US$ Million) Table 108. ChemoCentryx, Inc. Corporation Information Table 109. ChemoCentryx, Inc. Description and Major Businesses Table 110. ChemoCentryx, Inc. Anca Vasculitis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 111. ChemoCentryx, Inc. Anca Vasculitis Drug Product Model Numbers, Pictures, Descriptions and Specifications Table 112. ChemoCentryx, Inc. Recent Developments Table 113. GlaxoSmithKline plc Corporation Information Table 114. GlaxoSmithKline plc Description and Major Businesses Table 115. GlaxoSmithKline plc Anca Vasculitis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 116. GlaxoSmithKline plc Anca Vasculitis Drug Product Model Numbers, Pictures, Descriptions and Specifications Table 117. GlaxoSmithKline plc Recent Developments Table 118. Kineta, Inc. Corporation Information Table 119. Kineta, Inc. Description and Major Businesses Table 120. Kineta, Inc. Anca Vasculitis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 121. Kineta, Inc. Anca Vasculitis Drug Product Model Numbers, Pictures, Descriptions and Specifications Table 122. Kineta, Inc. Recent Developments Table 123. Key Raw Materials Lists Table 124. Raw Materials Key Suppliers Lists Table 125. Anca Vasculitis Drug Distributors List Table 126. Anca Vasculitis Drug Customers List Table 127. Anca Vasculitis Drug Market Trends Table 128. Anca Vasculitis Drug Market Drivers Table 129. Anca Vasculitis Drug Market Challenges Table 130. Anca Vasculitis Drug Market Restraints Table 131. Research Programs/Design for This Report Table 132. Key Data Information from Secondary Sources Table 133. Key Data Information from Primary Sources List of Figures Figure 1. Anca Vasculitis Drug Product Picture Figure 3. Global Anca Vasculitis Drug Market Share by Type in 2021 & 2028 Figure 3. Belimumab Product Picture Figure 4. CCX-1378 Product Picture Figure 5. CCX-168 Product Picture Figure 6. Dalazatide Product Picture Figure 7. Others Product Picture Figure 8. Global Anca Vasculitis Drug Market Share by Application in 2021 & 2028 Figure 9. Hospital Figure 10. Clinic Figure 11. Others Figure 12. Anca Vasculitis Drug Report Years Considered Figure 13. Global Anca Vasculitis Drug Sales 2017-2028 (K Pcs) Figure 14. Global Anca Vasculitis Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 15. Global Anca Vasculitis Drug Revenue 2017-2028 (US$ Million) Figure 16. Global Anca Vasculitis Drug Revenue Market Share by Region in Percentage: 2021 Versus 2028 Figure 17. Global Anca Vasculitis Drug Sales Market Share by Region (2017-2022) Figure 18. Global Anca Vasculitis Drug Sales Market Share by Region (2023-2028) Figure 19. North America Anca Vasculitis Drug Sales YoY (2017-2028) & (K Pcs) Figure 20. North America Anca Vasculitis Drug Revenue YoY (2017-2028) & (US$ Million) Figure 21. Europe Anca Vasculitis Drug Sales YoY (2017-2028) & (K Pcs) Figure 22. Europe Anca Vasculitis Drug Revenue YoY (2017-2028) & (US$ Million) Figure 23. Asia-Pacific Anca Vasculitis Drug Sales YoY (2017-2028) & (K Pcs) Figure 24. Asia-Pacific Anca Vasculitis Drug Revenue YoY (2017-2028) & (US$ Million) Figure 25. Latin America Anca Vasculitis Drug Sales YoY (2017-2028) & (K Pcs) Figure 26. Latin America Anca Vasculitis Drug Revenue YoY (2017-2028) & (US$ Million) Figure 27. Middle East & Africa Anca Vasculitis Drug Sales YoY (2017-2028) & (K Pcs) Figure 28. Middle East & Africa Anca Vasculitis Drug Revenue YoY (2017-2028) & (US$ Million) Figure 29. The Anca Vasculitis Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021 Figure 30. The Top 5 and 10 Largest Manufacturers of Anca Vasculitis Drug in the World: Market Share by Anca Vasculitis Drug Revenue in 2021 Figure 31. Global Anca Vasculitis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021 Figure 32. Global Anca Vasculitis Drug Sales Market Share by Type (2017-2028) Figure 33. Global Anca Vasculitis Drug Revenue Market Share by Type (2017-2028) Figure 34. Global Anca Vasculitis Drug Sales Market Share by Application (2017-2028) Figure 35. Global Anca Vasculitis Drug Revenue Market Share by Application (2017-2028) Figure 36. North America Anca Vasculitis Drug Sales Market Share by Type (2017-2028) Figure 37. North America Anca Vasculitis Drug Revenue Market Share by Type (2017-2028) Figure 38. North America Anca Vasculitis Drug Sales Market Share by Application (2017-2028) Figure 39. North America Anca Vasculitis Drug Revenue Market Share by Application (2017-2028) Figure 40. North America Anca Vasculitis Drug Sales Share by Country (2017-2028) Figure 41. North America Anca Vasculitis Drug Revenue Share by Country (2017-2028) Figure 42. U.S. Anca Vasculitis Drug Revenue (2017-2028) & (US$ Million) Figure 43. Canada Anca Vasculitis Drug Revenue (2017-2028) & (US$ Million) Figure 44. Europe Anca Vasculitis Drug Sales Market Share by Type (2017-2028) Figure 45. Europe Anca Vasculitis Drug Revenue Market Share by Type (2017-2028) Figure 46. Europe Anca Vasculitis Drug Sales Market Share by Application (2017-2028) Figure 47. Europe Anca Vasculitis Drug Revenue Market Share by Application (2017-2028) Figure 48. Europe Anca Vasculitis Drug Sales Share by Country (2017-2028) Figure 49. Europe Anca Vasculitis Drug Revenue Share by Country (2017-2028) Figure 50. Germany Anca Vasculitis Drug Revenue (2017-2028) & (US$ Million) Figure 51. France Anca Vasculitis Drug Revenue (2017-2028) & (US$ Million) Figure 52. U.K. Anca Vasculitis Drug Revenue (2017-2028) & (US$ Million) Figure 53. Italy Anca Vasculitis Drug Revenue (2017-2028) & (US$ Million) Figure 54. Russia Anca Vasculitis Drug Revenue (2017-2028) & (US$ Million) Figure 55. Asia Pacific Anca Vasculitis Drug Sales Market Share by Type (2017-2028) Figure 56. Asia Pacific Anca Vasculitis Drug Revenue Market Share by Type (2017-2028) Figure 57. Asia Pacific Anca Vasculitis Drug Sales Market Share by Application (2017-2028) Figure 58. Asia Pacific Anca Vasculitis Drug Revenue Market Share by Application (2017-2028) Figure 59. Asia Pacific Anca Vasculitis Drug Sales Share by Region (2017-2028) Figure 60. Asia Pacific Anca Vasculitis Drug Revenue Share by Region (2017-2028) Figure 61. China Anca Vasculitis Drug Revenue (2017-2028) & (US$ Million) Figure 62. Japan Anca Vasculitis Drug Revenue (2017-2028) & (US$ Million) Figure 63. South Korea Anca Vasculitis Drug Revenue (2017-2028) & (US$ Million) Figure 64. India Anca Vasculitis Drug Revenue (2017-2028) & (US$ Million) Figure 65. Australia Anca Vasculitis Drug Revenue (2017-2028) & (US$ Million) Figure 66. Taiwan Anca Vasculitis Drug Revenue (2017-2028) & (US$ Million) Figure 67. Indonesia Anca Vasculitis Drug Revenue (2017-2028) & (US$ Million) Figure 68. Thailand Anca Vasculitis Drug Revenue (2017-2028) & (US$ Million) Figure 69. Malaysia Anca Vasculitis Drug Revenue (2017-2028) & (US$ Million) Figure 70. Philippines Anca Vasculitis Drug Revenue (2017-2028) & (US$ Million) Figure 71. Latin America Anca Vasculitis Drug Sales Market Share by Type (2017-2028) Figure 72. Latin America Anca Vasculitis Drug Revenue Market Share by Type (2017-2028) Figure 73. Latin America Anca Vasculitis Drug Sales Market Share by Application (2017-2028) Figure 74. Latin America Anca Vasculitis Drug Revenue Market Share by Application (2017-2028) Figure 75. Latin America Anca Vasculitis Drug Sales Share by Country (2017-2028) Figure 76. Latin America Anca Vasculitis Drug Revenue Share by Country (2017-2028) Figure 77. Mexico Anca Vasculitis Drug Revenue (2017-2028) & (US$ Million) Figure 78. Brazil Anca Vasculitis Drug Revenue (2017-2028) & (US$ Million) Figure 79. Argentina Anca Vasculitis Drug Revenue (2017-2028) & (US$ Million) Figure 80. Middle East and Africa Anca Vasculitis Drug Sales Market Share by Type (2017-2028) Figure 81. Middle East and Africa Anca Vasculitis Drug Revenue Market Share by Type (2017-2028) Figure 82. Middle East and Africa Anca Vasculitis Drug Sales Market Share by Application (2017-2028) Figure 83. Middle East and Africa Anca Vasculitis Drug Revenue Market Share by Application (2017-2028) Figure 84. Middle East and Africa Anca Vasculitis Drug Sales Share by Country (2017-2028) Figure 85. Middle East and Africa Anca Vasculitis Drug Revenue Share by Country (2017-2028) Figure 86. Turkey Anca Vasculitis Drug Revenue (2017-2028) & (US$ Million) Figure 87. Saudi Arabia Anca Vasculitis Drug Revenue (2017-2028) & (US$ Million) Figure 88. UAE Anca Vasculitis Drug Revenue (2017-2028) & (US$ Million) Figure 89. Anca Vasculitis Drug Value Chain Figure 90. Anca Vasculitis Drug Production Process Figure 91. Channels of Distribution Figure 92. Distributors Profiles Figure 93. Bottom-up and Top-down Approaches for This Report Figure 94. Data Triangulation Figure 95. Key Executives Interviewed

ChemoCentryx, Inc. GlaxoSmithKline plc Kineta, Inc.